NCT05516992: An ongoing trial by Spine BioPharma, Inc
This trial is ongoing. It must report results 3 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05516992 |
|---|---|
| Title | A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Safety and Efficacy of SB-01 For Injection for the Treatment of Lumbar Degenerative Disc Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 19, 2022 |
| Completion date | March 21, 2025 |
| Required reporting date | March 21, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |